|
[1]European Association for the Study of the Liver.EASL recommendations on treatment of hepatitis C 2016[J].J Hepatol,2016.[Epub ahead of print]
|
|
[2]ASAHINA Y,IZUMI N,HIROMITSU K,et al.JSH guidelines for the management of hepatitis C virus infection:a 2016 update for genotype 1 and 2[J].Hepatol Res,2016,46(2):129-165.
|
|
[3]OMATA M,KANDA T,WEI L,et al.APASL consensus statements and recommendation on treatment of hepatitis C[J].Hepatol Int,2016,10(5):702-726.
|
|
[4]DAI MJ,FANG Y,LI CY,et al.Interpretation and analysis of the latest guidelines for the treatment of hepatitis C virus by European Association for the Study of the Liver[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2015,9(1):126-129.(in Chinese)戴明佳,方圆,李春杨,等.欧洲肝病学会最新HCV治疗指南解读及分析[J/CD].中华实验和临床感染病杂志:电子版,2015,9(1):126-129.
|
|
[5]DAI MJ,YAN XB.A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy[J].J Clin Hepatol,2015,31(10):1595-1598.(in Chinese)戴明佳,颜学兵.2014年与2015年欧洲肝病学会抗HCV治疗指南比较[J].临床肝胆病杂志,2015,31(10):1595-1598.
|
|
[6]WHO Library Cataloguing-in-Publication Data.Guidelines for the screening,care and treatment of persons with hepatitis C infection[EB/OL].http://www.who.int/hiv/topics/hepatitis/en/.
|
|
[7]ZHANG Y,ZHANG FK.Key points in treatment recommendations for hepatitis C by European Association for the Study of the Liver in2016[J].J Clin Hepatol,2016,32(12):2248-2257.(in Chinese)张影,张福奎.《2016年欧洲肝病学会丙型肝炎治疗推荐意见》要点[J].临床肝胆病杂志,2016,32(12):2248-2257.
|
|
[8] Chinese Society of Hepatology,Chinese Medical Association.Minutes of CSH-AASLD and CSH-AASLD joint academic conference on liver disease in 2016[C].Beijing:Chinese Society of Hepatology,Chinese Medical Association,2016.(in Chinese)中华医学会肝病学分会.2016 CSH-AASLD及CSH-EASL肝病联合学术会议纪要[C].北京:中华医学会肝病学分会,2016.
|
DownLoad: